ARTICLE | Company News
Exten other research news
February 5, 2001 8:00 AM UTC
EXTI's Xenogenics subsidiary received a $100,000 Phase I SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases to extend the life of cells via improved membranes and oxy...